Brief review: cell replacement therapies to treat type 1 diabetes mellitus.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28702240)

Published in Clin Diabetes Endocrinol on February 25, 2016

Authors

Alberto Hayek1, Charles C King2

Author Affiliations

1: Scripps Whittier Diabetes Institute, La Jolla, CA 92037 USA.
2: Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA 92093 USA.

Articles cited by this

Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21

Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63

Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol (2006) 10.95

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol (2008) 10.60

Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol (2005) 9.58

Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc (2007) 7.01

Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A (2000) 3.80

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol (2014) 3.20

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells (2005) 3.05

Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells (2007) 3.04

Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med (2006) 2.83

Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science (2004) 2.67

Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes (2012) 2.40

A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One (2012) 2.24

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes (2008) 2.23

Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med (2006) 2.21

Insulin production by human embryonic stem cells. Diabetes (2001) 2.20

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant (2012) 2.12

Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol (2013) 2.06

Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes (2012) 1.98

Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells (2004) 1.73

Expression of islet-specific microRNAs during human pancreatic development. Gene Expr Patterns (2008) 1.48

Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus. Dev Biol (2004) 1.47

Differentiated human stem cells resemble fetal, not adult, β cells. Proc Natl Acad Sci U S A (2014) 1.44

Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature (1973) 1.42

Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Res (2009) 1.37

Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J (2015) 1.34

Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. PLoS One (2009) 1.32

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes (2013) 1.15

A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes. Am J Transplant (2015) 1.14

Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes (2011) 1.13

Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08

Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant (2006) 1.06

Redifferentiation of expanded human pancreatic β-cell-derived cells by inhibition of the NOTCH pathway. J Biol Chem (2012) 1.04

Transplantation of islets of Langerhans in diabetic rhesus monkeys. Surgery (1975) 1.02

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med (2012) 1.02

Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00

Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest (2015) 0.98

Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev (2012) 0.90

Current status of islet xenotransplantation. Int J Surg (2015) 0.89

Long-Term Control of Diabetes in Immunosuppressed Nonhuman Primates (NHP) by the Transplantation of Adult Porcine Islets. Am J Transplant (2015) 0.88

Reprogramming of human pancreatic exocrine cells to β-like cells. Cell Death Differ (2014) 0.87

Abnormalities of the Exocrine Pancreas in Type 1 Diabetes. Curr Diab Rep (2015) 0.87

MiR-375 promotes redifferentiation of adult human β cells expanded in vitro. PLoS One (2015) 0.84

Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo. Stem Cells Transl Med (2015) 0.84

Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense? Stem Cells Dev (2015) 0.84

Morphology and function of cultured human fetal pancreatic cells transplanted into athymic mice: a longitudinal study. Cell Transplant (1995) 0.82

Tri-iodothyronine differentially induces Kupffer cell ED1/ED2 subpopulations. Mol Aspects Med (2004) 0.80

Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80

Justifying clinical trials for porcine islet xenotransplantation. Xenotransplantation (2015) 0.79

Development of an encapsulated stem cell-based therapy for diabetes. Expert Opin Biol Ther (2015) 0.78

TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In Vitro. PLoS One (2015) 0.76

In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76

BMP-7 Induces Adult Human Pancreatic Exocrine-to-Endocrine Conversion. Diabetes (2015) 0.75